Literature DB >> 2539117

Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy.

K Toda1, T Kobayashi, I Goto, T Kurokawa, K Ogomori.   

Abstract

Abnormal accumulation of lysosulfatide (sulfogalactosylsphingosine) was evident in autopsied tissues from a boy with late-infantile metachromatic leukodystrophy. The concentration was high in the cerebral white matter, spinal cord and sciatic nerve (116-787 pmol/mg protein) and low in the cerebral gray matter, kidney and liver (4-40 pmol/mg protein). As is the case with galactosylsphingosine, lysosulfatide inhibited cytochrome c oxidase activity, in a dose-dependent manner. Judging from the tissue distribution of the accumulated lysosulfatide and because of the cytotoxicity, the lysosulfatide presumably explains the demyelination seen in the nervous tissues of patients with metachromatic leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539117     DOI: 10.1016/0006-291x(89)90037-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  A novel assay method for glycosphingolipid deacylase by enzyme-linked immunochemical detection of lysoglycosphingolipid.

Authors:  K Izumi; M T Sawada
Journal:  Lipids       Date:  2001-01       Impact factor: 1.880

2.  Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry.

Authors:  Mina Mirzaian; Gertjan Kramer; Ben J H M Poorthuis
Journal:  J Lipid Res       Date:  2015-01-27       Impact factor: 5.922

Review 3.  Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status.

Authors:  K Suzuki
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 4.  Pathology and current treatment of neurodegenerative sphingolipidoses.

Authors:  Matthias Eckhardt
Journal:  Neuromolecular Med       Date:  2010-08-22       Impact factor: 3.843

5.  Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action.

Authors:  E Tubaro; C Santiangeli; G Cavallo; L Belogi; G Guida; C Croce; A Modesti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

6.  Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.

Authors:  Maria Blomqvist; Volkmar Gieselmann; Jan-Eric Månsson
Journal:  Lipids Health Dis       Date:  2011-02-07       Impact factor: 3.876

7.  Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.

Authors:  Christopher J Folts; Nicole Scott-Hewitt; Christoph Pröschel; Margot Mayer-Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2016-12-15       Impact factor: 8.029

Review 8.  Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer.

Authors:  Patricia Dubot; Leonardo Astudillo; Nicole Therville; Lorry Carrié; Magali Pettazzoni; David Cheillan; Jérôme Stirnemann; Thierry Levade; Nathalie Andrieu-Abadie; Frédérique Sabourdy
Journal:  Cancers (Basel)       Date:  2022-10-05       Impact factor: 6.575

Review 9.  Developing therapeutic approaches for metachromatic leukodystrophy.

Authors:  Shilpa A Patil; Gustavo H B Maegawa
Journal:  Drug Des Devel Ther       Date:  2013-08-08       Impact factor: 4.162

Review 10.  Lyso-glycosphingolipids: presence and consequences.

Authors:  Marco van Eijk; Maria J Ferraz; Rolf G Boot; Johannes M F G Aerts
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.